Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Doctors scrutinize past COVID treatments for most vulnerable patients

NCT ID NCT06683937

Summary

This study looks back at medical records to see how well two antiviral drugs, nirmatrelvir/ritonavir (Paxlovid) and remdesivir (Veklury), worked for immunocompromised adults hospitalized with COVID-19 in France. Researchers will analyze data from about 300 patients who were treated between June 2023 and April 2024. The goal is to gather better evidence on which treatment strategies are most effective for this high-risk group.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNOCOMPROMISED PATIENTS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CH Périgueux

    Périgueux, 24000, France

    Contact Email: •••••@•••••

  • CHD Vendée (La Roche sur Yon)

    La Roche-sur-Yon, 85000, France

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

  • CHRU Lille

    Lille, 59000, France

    Contact Email: •••••@•••••

  • CHU Angers

    Angers, 49000, France

    Contact Email: •••••@•••••

  • CHU Caen

    Caen, 14000, France

    Contact Email: •••••@•••••

  • CHU Nantes

    Nantes, 44000, France

    Contact Email: •••••@•••••

  • CHU Nord Marseille

    Marseille, 13000, France

    Contact Email: •••••@•••••

  • CHU Nîmes Caremeau

    Nîmes, 30000, France

    Contact Email: •••••@•••••

  • CHU Poitiers

    Poitiers, 86000, France

    Contact Email: •••••@•••••

  • CHU Reims

    Reims, 51100, France

    Contact Email: •••••@•••••

  • CHU Sud Réunion

    Saint-Pierre, 97410, France

    Contact Email: •••••@•••••

  • CHU Toulouse

    Toulouse, 31000, France

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

  • Hôpital Bichat

    Paris, 75018, France

    Contact Email: •••••@•••••

  • Hôpital Necker-Enfants Malades

    Paris, 75015, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hôpital Pasteur, Colmar

    Colmar, 68000, France

    Contact Email: •••••@•••••

  • Hôpital Saint-Louis

    Paris, 75010, France

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.